Trials / Conditions / COVID-19 Drug Treatment
COVID-19 Drug Treatment
5 registered clinical trials studyying COVID-19 Drug Treatment.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | A Study to Learn About the Patients With COVID-19 Prescribed Paxlovid in Morocco NCT05997485 | Pfizer | — |
| Completed | Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase NCT04466241 | ANRS, Emerging Infectious Diseases | Phase 2 / Phase 3 |
| Completed | Telmisartan for Treatment of COVID-19 Patients NCT04355936 | Laboratorio Elea Phoenix S.A. | Phase 4 |
| Completed | Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19 NCT04381884 | Laboratorio Elea Phoenix S.A. | Phase 2 |
| Unknown | Sarilumab Treatment In cytoKinE Storm Caused by Infection With COVID-19 NCT04661527 | Clinica Universidad de Navarra, Universidad de Navarra | Phase 2 |